Oxaliplatin In Operable Colorectal CancerA Viewpoint by Gérard Milano

被引：0
|
作者：
Gérard Milano
机构：
[1] Centre Antoine Lacassagne,Oncopharmacology Unit
来源：
Drugs | 2005年 / 65卷
关键词：
Vascular Endothelial Growth Factor; Epidermal Growth Factor Receptor; Irinotecan; Oxaliplatin; Leucovorin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 97
相关论文
共 33 条
  • [11] Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G0/G1 to Apoptosis in HCT116 Human Colorectal Carcinoma Cells
    Jang, Chan Ho
    Moon, Nayoung
    Oh, Jisun
    Kim, Jong-Sang
    NUTRIENTS, 2019, 11 (04)
  • [12] MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kang, B. W.
    Kim, J. G.
    Chae, Y. S.
    Lee, S. J.
    Do, Y. R.
    Lee, W. S.
    ANNALS OF ONCOLOGY, 2010, 21 : 209 - 210
  • [13] MGMT-535G>T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kim, J. G. K.
    Choi, G. S. C.
    Chung, H. Y. C.
    Jun, S. H. J.
    Lim, K. H. L.
    Kang, B. W. K.
    Jeon, S. W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : I35 - I35
  • [14] Exploratory analysis of predictive biomarkers of oxaliplatin versus irinotecan in combination with bevacizumab for patients with metastatic colorectal cancer in WJOG4407G study
    Fujita, Y.
    Yamazaki, K.
    Oba, M. S.
    Muro, K.
    Negoro, Y.
    Yoshida, M.
    Suyama, K.
    Kurimoto, T.
    Sugimoto, N.
    Seki, N.
    Sato, M.
    Ebi, M.
    Tamagawa, H.
    Ueda, S.
    Tamura, T.
    Boku, N.
    Hyodo, I.
    Yamanaka, T.
    Tsurutani, J.
    Nishio, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S384 - S384
  • [15] EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
    Spindler, K. -L. G.
    Andersen, R. F.
    Jensen, L. H.
    Ploen, J.
    Jakobsen, A.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 535 - 539
  • [16] MGMT-535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Park, Jee Hyun
    Kim, Nung Soo
    Park, Jae Yong
    Chae, Yee Soo
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kang, Byung Woog
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Choi, Gyu Seog
    Jun, Soo-Han
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1135 - 1142
  • [17] Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal CancerA Phase II StudyPräoperative kombinierte Radiochemotherapie mit Oxaliplatin und Capecitabin beim lokal fortgeschrittenen, primär operablen, cT3NxM0, tiefen Rektumkarzinom – eine Phase-II-Studie
    Dietmar Öfner
    Alexander F. DeVries
    Renate Schaberl-Moser
    Richard Greil
    Hans Rabl
    Jörg Tschmelitsch
    Matthias Zitt
    Karin S. Kapp
    Gerd Fastner
    Felix Keil
    Wolfgang Eisterer
    Robert Jäger
    Felix Offner
    Michael Gnant
    Josef Thaler
    Strahlentherapie und Onkologie, 2011, 187 (2) : 100 - 107
  • [18] Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
    Chae, Y.
    Kim, J.
    Sohn, S.
    Kang, B.
    Ryoo, H.
    Bae, S.
    Choi, G.
    Baek, J.
    Kim, Y.
    Cho, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [19] A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G)
    Machida, Nozomu
    Okumura, Takehiro
    Boku, Narikazu
    Kishimoto, Junji
    Nishina, Tomohiro
    Suyama, Koichi
    Ohde, Yasuhisa
    Shinozaki, Katsunori
    Baba, Hideo
    Tokunaga, Shinya
    Kawakami, Hisato
    Tsuda, Takashi
    Kotaka, Masahito
    Okuda, Hiroyuki
    Yasui, Hisateru
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Muro, Kei
    Hyodo, Ichinosuke
    CANCER, 2025, 131 (07)
  • [20] Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer
    Xu, Kaiwu
    Chen, Zhihui
    Cui, Yi
    Qin, Changjiang
    He, Yulong
    Song, Xinming
    ONCOTARGETS AND THERAPY, 2015, 8 : 3047 - 3054
1234